Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Prevacid, Prevacid SoluTab, Zoton
Lansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is used in the treatment of stomach ulcers and GERD.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| GERD (Gastroesophageal reflux disease) | 114 | 23 |
|
|
|
|
|
| Acid reflux | 89 | 17 |
|
|
|
|
|
| Other | 43 | 6 |
|
|
|||
| General health | 17 | 2 |
|
|
|||
| Hiatus Hernia | 11 | 3 |
|
|
|
||
| Support digestive health | 7 | 3 |
|
|
|
See all 268 patients currently taking Lansoprazole
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Lansoprazole
| Loose stools | 1 | |
|---|---|---|
| Nausea sometimes | 1 | |
| Stomach upset | 1 | |
| Bloating | 1 | |
| Vitamin B12 deficiency | 1 | |
| Iron deficiency | 1 |
Frequently reported dosages based on patients currently taking Lansoprazole. See all 17 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 27 | ||
| Doctor's advice | 21 | ||
| Other | 21 | ||
| Change in health plan coverage | 10 | ||
| Course of treatment ended | 9 | ||
| Expense | 7 | ||
| Side effects too severe | 6 | ||
| Personal research | 3 | ||
| Not indicated | 2 |
Adherence
Taking treatment as prescribed
Adherence of Lansoprazole
Always |
46 | 81% |
|
|---|---|---|---|
Usually |
9 | 16% |
|
Sometimes |
1 | 2% |
|
Never |
1 | 2% |
|
Burden
Difficulty being on treatment
Burden of Lansoprazole
Very |
1 | 2% |
|
|---|---|---|---|
Somewhat |
3 | 5% |
|
A little |
7 | 12% |
|
Not at all |
46 | 81% |
|
Cost
Paid out of pocket
Cost of Lansoprazole
$200+ |
1 | 3% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
9 | 23% |
|
< $25 |
29 | 74% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.